Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bertram Wiedenmann

Showing results (1-10 of 252) with videos related to

Pageof 26
Sort By:
Gastroenterologie Clinique Et Biologique|April 22, 2003
[Neuroendocrine tumors of the pancreas. Natural history and therapeutic options]Bertram Wiedenmann
Nature Reviews. Clinical Oncology|February 28, 2019
Reply to 'Time for a change and to adopt a novel molecular genomic approach in NETs'Guido Rindi, Bertram Wiedenmann
Neuroendocrinology|February 7, 2018
Extremely Long Survival under Combined Immunotherapy in a Metastatic Functional Neuroendocrine Neoplasia PatientDaniel Schmidt, Bertram Wiedenmann
Endocrine-Related Cancer|January 10, 2004
The management of patients with neuroendocrine tumoursMartyn Caplin, Bertram Wiedenmann
Nature Reviews. Endocrinology|August 26, 2020
Neuroendocrine neoplasia of the gastrointestinal tract revisited: towards precision medicineGuido Rindi, Bertram Wiedenmann
Annals of the New York Academy of Sciences|May 22, 2004
Somatostatin receptor targeting for tumor imaging and therapyCarsten Grötzinger, Bertram Wiedenmann
Neuroendocrinology|November 14, 2012
ForewordHåkan Ahlman, Bertram Wiedenmann
Nature Reviews. Clinical Oncology|November 4, 2018
Neuroendocrine neoplasia goes molecular - time for a changeGuido Rindi, Bertram Wiedenmann
Nature Reviews. Endocrinology|August 3, 2011
Neuroendocrine neoplasms of the gut and pancreas: new insightsGuido Rindi, Bertram Wiedenmann
Oncotarget|May 31, 2019
Sustained partial remission of a metastatic NEN using off-label immunotherapy with pembrolizumabAnna Kathrin Stüven, Bertram Wiedenmann
Pageof 26

Showing results (1-10 of 252) with videos related to

Sort By:
Pageof 26
Gastroenterologie Clinique Et Biologique|April 22, 2003
[Neuroendocrine tumors of the pancreas. Natural history and therapeutic options]Bertram Wiedenmann
Nature Reviews. Clinical Oncology|February 28, 2019
Reply to 'Time for a change and to adopt a novel molecular genomic approach in NETs'Guido Rindi, Bertram Wiedenmann
Neuroendocrinology|February 7, 2018
Extremely Long Survival under Combined Immunotherapy in a Metastatic Functional Neuroendocrine Neoplasia PatientDaniel Schmidt, Bertram Wiedenmann
Endocrine-Related Cancer|January 10, 2004
The management of patients with neuroendocrine tumoursMartyn Caplin, Bertram Wiedenmann
Nature Reviews. Endocrinology|August 26, 2020
Neuroendocrine neoplasia of the gastrointestinal tract revisited: towards precision medicineGuido Rindi, Bertram Wiedenmann
Annals of the New York Academy of Sciences|May 22, 2004
Somatostatin receptor targeting for tumor imaging and therapyCarsten Grötzinger, Bertram Wiedenmann
Neuroendocrinology|November 14, 2012
ForewordHåkan Ahlman, Bertram Wiedenmann
Nature Reviews. Clinical Oncology|November 4, 2018
Neuroendocrine neoplasia goes molecular - time for a changeGuido Rindi, Bertram Wiedenmann
Nature Reviews. Endocrinology|August 3, 2011
Neuroendocrine neoplasms of the gut and pancreas: new insightsGuido Rindi, Bertram Wiedenmann
Oncotarget|May 31, 2019
Sustained partial remission of a metastatic NEN using off-label immunotherapy with pembrolizumabAnna Kathrin Stüven, Bertram Wiedenmann
Pageof 26